The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Surely as a % of our own mcap rather than Biogens is possible ( think biogens jump was worth 18 billuion usd ) which quid pro qou about 112 million pound sterling ?
i would have thought press soundbites of capturing cancer cells etc in unison with trials of oncology services ,detection and hopefully cure of the same would garner great interest ,that also allowing for amount of shares in issue and sticky vice like grip holders hands.
think also the uk press ergo most other countries have this as a big story helps
ANGLE is following a De Novo FDA process for the Parsortix system, as there is no predicate device. Consequently, there is inherent uncertainty over the timing of the process and its ultimate success.
We have discussed this before ,being that there is no yardstick to compare ,measure and get data from etc ,does not concern me ,in fact this Amplifies The Potential Here
so do posters think that if this further submission was not required then we could have got FDA approval now or already ?
Also is there a certain timeframe or at least anecdotal evidence that shows on norm how long after AIR does FDA Approval got ?
o/t apologies for of topic but Portage Biotech are doing some amazing stuff re Oncology ,was lucky to get in early this year prior to nasdaq listing ,larger volumes than normal ,lot in the pipeline and connections
So could Parsortix be used for a screening system ( we have discussed that our current FDA Approval is based on gleaned data and Parsortix catches CTC’s ) so it catches all cancerous CTC’ s .
So where a mamogram or similiar ie none invasive detection system is not applicable could Parsortix exactly do this ?
https://www.egtechnology.co.uk/casestudies/angle-plc-parsortix-instrument
So I have seen somewhere the costs to build and buy also test costs etc .
So how many Parsortix PR1 systems will there be in use at the moment .
How many ‘ on the shelf ‘ will they have and lastly how easily can they be made in volume ty